BRIEF-Ligand enters into commercial license, supply agreement with Amgen By: Reuters: Company News July 17, 2017 at 09:27 AM EDT * Ligand enters into commercial license and supply agreement with Amgen for rights to use captisol in the formulation of AMG 330 Read More >> Related Stocks: Amgen Ligand Pharm